Greg Thurber

24PUBLICATIONS
39CO-AUTHORS
Pharmaceutical delivery technologiesMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 03, 2026
Single-cell spatial pharmacobiology identifies conserved stromal barriers to therapeutic antibody delivery in human solid tumors.

|May 26, 2026
Agent-based modeling demonstrates how target-independent processes supplement killing by antibody-drug conjugates in cancer therapy.

|Jan 07, 2026
Oral Administration of a Bivalent Carbonic Anhydrase IX Near-Infrared Imaging Agent Detects Hypoxic Tumors in a Mouse Model.

Haolong Huang, Matthew Proefke, Eshita Khera

|Jan 06, 2026
Combining antibody conjugates with cytotoxic and immune-stimulating payloads maximizes anti-cancer activity.

Tiexin Wang, Dong Jun Koo, Peter M Tessier

|Dec 30, 2025
In Vivo Auto-tuning of Antibody-Drug Conjugate Delivery to Maximize Efficacy Using High-Avidity, Low-Affinity Antibodies.

Anna Kopp, Shujun Dong, Hyeyoung Kwon

|Dec 17, 2025
Impacts of Antibody Structure and Mixtures on Receptor Signaling for Antibody-Dependent Cellular Cytotoxicity.

Jiakun Guan, Tiexin Wang, Peter M Tessier

Pageof 4

Frequent Collaborators

3 joint publications

Peter Tessier

3 joint publications

Anna Kopp

2 joint publications

Alec A Desai

2 joint publications

Guolan Lu